CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Caladrius Biosciences, Inc.  (NBS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

NBS's Net Income Year on Year Growth by Quarter and Year

Caladrius Biosciences,'s Net Income results by quarter and year



Select the Comparisons : Select the Ratio:                        
NBS Net Income (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - -6.09 -33.23 -11.69
III Quarter September - -7.29 -11.39 -17.18
II Quarter June 38.47 -7.88 -17.16 -12.77
I Quarter March -9.79 -12.05 -19.23 -13.83
FY   28.68 -33.31 -81.01 -55.47

Financial Statements
Caladrius Biosciences,'s second quarter 2017 Net Income $ 38.47 millions NBS's Income Statement
Caladrius Biosciences,'s second quarter 2016 Net Income $ -7.88 millions Quarterly NBS's Income Statement
NBS's Growth by Division See NBS's Growth by Segment

NBS Net Income ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -



NBS Net Income Growth Comment
Caladrius Biosciences, Inc. in the second quarter achieved Net Income of $ 38.47 millions compare to net loss recorded in same quarter a year ago.

According to the results reported in the second quarter, Caladrius Biosciences, Inc. achieved the best Net Income growth in Biotechnology & Drugs industry. While Caladrius Biosciences, Inc.' s Net Income no change of % ranks overall at the positon no. 0 in the second quarter.



Net Income Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

You need to upgrade your Flash Player

Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
NBS's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for NBS's Competitors
Net Income Growth for Caladrius Biosciences,'s Suppliers
Net Income Growth for NBS's Customers

You may also want to know
NBS's Annual Growth Rates NBS's Profitability Ratios NBS's Asset Turnover Ratio NBS's Dividend Growth
NBS's Roe NBS's Valuation Ratios NBS's Financial Strength Ratios NBS's Dividend Payout Ratio
NBS's Roa NBS's Inventory Turnover Ratio NBS's Growth Rates NBS's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2017
Quest Diagnostics Inc -0.96 %$ -0.957 millions
Alpha Pro Tech Ltd -1.52 %$ -1.515 millions
Luminex Corp -1.93 %$ -1.928 millions
Healthsouth Corp -2.22 %$ -2.217 millions
Universal Health Services Inc -2.59 %$ -2.589 millions
Laboratory Corp Of America Holdings -4.84 %$ -4.836 millions
Jazz Pharmaceuticals Plc -5.10 %$ -5.102 millions
China Biologic Products Holdings, Inc. -7.08 %$ -7.082 millions
Acadia Healthcare Company, Inc. -10.71 %$ -10.709 millions
National Healthcare Corp -10.93 %$ -10.930 millions
Gilead Sciences Inc -12.24 %$ -12.239 millions
Alliance Healthcare Services, Inc -13.66 %$ -13.655 millions
Integra Lifesciences Holdings Corp -15.05 %$ -15.053 millions
Biogen Inc. -17.70 %$ -17.703 millions
Tenet Healthcare Corp -17.95 %$ -17.949 millions
Bristol Myers Squibb Co -22.39 %$ -22.391 millions
Mednax, Inc. -22.63 %$ -22.626 millions
U.s. Neurosurgical Holdings, Inc. -23.16 %$ -23.164 millions
Pra Health Sciences, Inc. -23.30 %$ -23.305 millions
Owens & Minor Inc -27.33 %$ -27.331 millions
Select Medical Holdings Corp -33.67 %$ -33.669 millions
U S Physical Therapy Inc -36.48 %$ -36.481 millions
Psychemedics Corp -44.48 %$ -44.484 millions
Capstone Therapeutics Corp. -47.18 %$ -47.179 millions
Abbott Laboratories -53.98 %$ -53.984 millions
Amedisys Inc -58.23 %$ -58.231 millions
Nuvasive Inc -58.95 %$ -58.949 millions
Lifeloc Technologies, Inc -59.11 %$ -59.112 millions
Biotelemetry, Inc. -60.18 %$ -60.185 millions
Msa Safety Incorporated -60.50 %$ -60.496 millions